Design and optimization of novel Tetrahydro-β-carboline-based HDAC inhibitors with potent activities against tumor cell growth and metastasis

被引:0
|
作者
Fan, Shule [1 ]
Wan, Zeyi [1 ]
Qu, Yuhua [1 ]
Lu, Wenxia [1 ]
Li, Xiangzhi [1 ]
Yang, Feifei [1 ]
Zhang, Hua [1 ]
机构
[1] Univ Jinan, Sch Biol Sci & Technol, Jinan 250022, Shandong Provin, Peoples R China
基金
中国国家自然科学基金;
关键词
Tetrahydro-beta-carboline; Hydroxamate; HDAC inhibitors; Antitumor;
D O I
10.1016/j.bmcl.2024.129986
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Histone deacetylases (HDACs) are validated drug targets for various therapeutic applications. A series of Tetrahydro-beta-carboline-based hydroxamate derivatives, designed as HDAC inhibitors (HDACis), were synthesized. Compound 11g exhibited strong inhibitory activity against HDAC1 and the A549 cancer cell line. Additionally, this compound increased the levels of acetylated histone H3 and H4. Notably, 11g effectively arrested A549 cells in the G2/M phase and also increased ROS production and DNA damage, thereby inducing apoptosis. Further molecular docking experiments illustrated the potential interactions between compound 11g and HDAC1. These findings suggested that the novel Tetrahydro-beta-carboline-based HDACis could serve as a promising framework for further optimization as anticancer agents.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Design of a novel analogue peptide with potent antibiofilm activities against Staphylococcus aureus based upon a sapecin B-derived peptide
    Akhash, Nasim
    Sheikh, Ahmad Farajzadeh
    Farshadzadeh, Zahra
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [32] Design of a novel analogue peptide with potent antibiofilm activities against Staphylococcus aureus based upon a sapecin B-derived peptide
    Nasim Akhash
    Ahmad Farajzadeh Sheikh
    Zahra Farshadzadeh
    Scientific Reports, 14
  • [33] Design and synthesis of novel pyrazolopyrimidine-based derivatives as reversible BTK inhibitors with potent antiproliferative activity in mantle cell lymphoma
    Ran, Fansheng
    Liu, Yang
    Zhao, Guisen
    MEDICINAL CHEMISTRY RESEARCH, 2022, 31 (04) : 594 - 604
  • [34] Design and synthesis of novel pyrazolopyrimidine-based derivatives as reversible BTK inhibitors with potent antiproliferative activity in mantle cell lymphoma
    Fansheng Ran
    Yang Liu
    Guisen Zhao
    Medicinal Chemistry Research, 2022, 31 : 594 - 604
  • [35] Optimization of Potent and Selective Tricyclic Indole Diazepinone Myeloid Cell Leukemia-1 Inhibitors Using Structure-Based Design
    Shaw, Subrata
    Bian, Zhiguo
    Zhao, Bin
    Tarr, James C.
    Veerasamy, Nagarathanam
    Jeon, Kyu Ok
    Belmar, Johannes
    Arnold, Allison L.
    Fogarty, Stuart A.
    Perry, Evan
    Sensintaffar, John L.
    Camper, DeMarco V.
    Rossanese, Olivia W.
    Lee, Taekyu
    Olejniczak, Edward T.
    Fesik, Stephen W.
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (06) : 2410 - 2421
  • [36] Potent synergistic tumor cell suppression from combination of ONC201 and epigenetic modulators EZH2 or HDAC inhibitors provides a novel treatment strategy for solid tumors
    Zhang, Yiqun
    Zhou, Lanlan
    Glantz, Michael
    Safran, Howard
    Seyhan, Attila
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2020, 80 (16)
  • [37] Novel inhibitors of fibroblast growth factor receptor 1 kinase: Lead optimization of thienopyrimidinones by structure-based design
    Ekkati, Anil R.
    Ravindranathan, Krishna P.
    Mandiyan, Valsan
    Bae, Jae H.
    Schlessinger, Joseph
    Jorgensen, William L.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [38] Discovery of Potent Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 Using a Novel Growth-Based Protocol of in Silico Screening and Optimization in CONTOUR
    Liu, Zhijie
    Singh, Suresh B.
    Zheng, Yajun
    Lindblom, Peter
    Tice, Colin
    Dong, Chengguo
    Zhuang, Linghang
    Zhao, Yi
    Kruk, Barbara A.
    Lala, Deepak
    Claremon, David A.
    McGeehan, Gerard M.
    Gregg, Richard D.
    Cain, Robert
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2019, 59 (08) : 3422 - 3436
  • [39] Novel quinoline-3-carboxamides (Part 2): Design, optimization and synthesis of quinoline based scaffold as EGFR inhibitors with potent anticancer activity
    Aly, Rasha M.
    Serya, Rabah A. T.
    El-Motwally, Amira M.
    Esmat, Ahmed
    Abbas, Safinaz
    Abou El Ella, Dalal A.
    BIOORGANIC CHEMISTRY, 2017, 75 : 368 - 392
  • [40] Structure-based design and optimization lead to the identification of novel dihydrothiopyrano [3,2-d]pyrimidine derivatives as potent HIV-1 inhibitors against drug-resistant variants
    Wang, Zhao
    Zhang, Heng
    Gao, Zhen
    Sang, Zihao
    De Clercq, Erik
    Pannecouque, Christophe
    Kang, Dongwei
    Zhan, Peng
    Liu, Xinyong
    ACTA PHARMACEUTICA SINICA B, 2024, 14 (03) : 1257 - 1282